SCHEDULE 13D

Company

Damora Therapeutics, Inc.

Filed

November 6, 2020

Accession Number

0000947871-20-000855

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →